ACCESSION: MSBNK-SMB_Measured-HSA015P0200010
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.03.05 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.05, Curated 2025.03.05)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 24
COMMENT: RAW_SPEC {'EL24_pos_2559': {'bp': 373788.0, 'sum': 904739.0}, 'EL19_pos_2531': {'bp': 289194.0, 'sum': 831943.0}, 'EL07_pos_2507': {'bp': 281886.0, 'sum': 809718.0}, 'EL20_pos_2501': {'bp': 281378.0, 'sum': 777484.0}, 'EL10_pos_2511': {'bp': 251371.0, 'sum': 692636.0}, 'EL22_pos_2524': {'bp': 309323.0, 'sum': 879057.0}, 'EL15_pos_2487': {'bp': 271538.0, 'sum': 789928.0}, 'EL03_pos_2770': {'bp': 238216.0, 'sum': 1011086.0}, 'EL23_pos_2522': {'bp': 361792.0, 'sum': 917760.0}, 'EL02_pos_2504': {'bp': 346733.0, 'sum': 952416.0}, 'EL05_pos_2512': {'bp': 324801.0, 'sum': 898041.0}, 'EL17_pos_2507': {'bp': 299459.0, 'sum': 799045.0}, 'EL08_pos_2518': {'bp': 312629.0, 'sum': 810121.0}, 'EL06_pos_2511': {'bp': 309368.0, 'sum': 870698.0}, 'EL18_pos_2511': {'bp': 244938.0, 'sum': 725317.0}, 'EL01_pos_2511': {'bp': 368142.0, 'sum': 898281.0}, 'EL04_pos_2541': {'bp': 340246.0, 'sum': 851573.0}, 'EL09_pos_2488': {'bp': 313830.0, 'sum': 834219.0}, 'EL21_pos_2500': {'bp': 242459.0, 'sum': 785353.0}, 'EL12_pos_2482': {'bp': 259094.0, 'sum': 781844.0}, 'EL11_pos_2482': {'bp': 201878.0, 'sum': 623550.0}, 'EL13_pos_2505': {'bp': 261658.0, 'sum': 716340.0}, 'EL16_pos_2489': {'bp': 288736.0, 'sum': 825236.0}, 'EL14_pos_2494': {'bp': 228878.0, 'sum': 697081.0}}
COMMENT: RETENTION_TIME_STDEV 0.078
COMMENT: PRECURSOR_M/Z_RAW 200.164748
COMMENT: PRECURSOR_M/Z_STDEV 0.000091
COMMENT: PRECURSOR_IN_MS1 mz 200.164513; int 39.435; delta(ppm) 1.070677
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.060; C11H21NO2; [M+H]+; delta(ppm) 0.060254
COMMENT: PROPOSED_MF MS-FINDER 3.196; C11H21NO2; [M+H]+; delta(ppm) 0.058186
COMMENT: PROPOSED_MF SIRIUS6_Sirius 4.679; C11H21NO2; [M+H]+; delta(ppm) 0.058186
COMMENT: PROPOSED_MF SIRIUS6_Sirius -3.298; C9H19N4O; [M+H]+; delta(ppm) 6.766032
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C11H21NO2; [M+H]+; delta(ppm) 0.058186
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.525; RAKAYJBOINMECV-UHFFFAOYNA-N; [M+H]+; CCCC1COC(=O)CCN1CCC
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.515; PTJTVVNZVPUVNP-MJNBVBEVNA-N; [M+H]+; C[C@@H]1[C@H](O)C[C@]2(O)[C@H]1CN(C)C[C@@H]2C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.409; WNNYIIINIZJRMW-VBADPVMMNA-N; [M+H]+; C[C@H]1CC[C@@H]2[C@H](C)CN(C)(=O)C[C@]12O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.383; UBTBXKBPQCPOTA-RLXAYYKLNA-N; [M+H]+; C[C@H](O)C[C@@H]1CC[C@H](CC(C)=O)N1C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.375; ZMYQHFQMRLPPRB-WSYQHHSTNA-N; [M+H]+; CCOC(=O)C[C@@H]1CCNC[C@@H]1CC
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.158; QSFROPSPQWQTKU-UHFFFAOYSA-N; [M+H]+; 11-nitro-1-undecene
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.158; WNNYIIINIZJRMW-VBADPVMMNA-N; [M+H]+; Kinabalurine G;(+)-Kinabalurine G
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.158; RAKAYJBOINMECV-UHFFFAOYNA-N; [M+H]+; microdiplactone
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.106; PTJTVVNZVPUVNP-MJNBVBEVNA-N; [M+H]+; UNPD91661
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.106; UBTBXKBPQCPOTA-RLXAYYKLNA-N; [M+H]+; UNPD112270
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.106; ZMYQHFQMRLPPRB-WSYQHHSTNA-N; [M+H]+; UNPD147128
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.053; ANMBNLBZNBYCLE-UHFFFAOYSA-N; [M+H]+; methyl N-ethyl-N-(hept-4-en-1-yl)carbamate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.053; CZPCDIVNIKVJDW-UHFFFAOYSA-N; [M+H]+; 3-amino-4-cyclohexylcyclopentane-1,2-diol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.053; SLIAVDGEVKKHIC-UHFFFAOYSA-N; [M+H]+; 5-methyl-2-(propan-2-yl)cyclohexyl carbamate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.053; ZUEKXFUSXSASAS-UHFFFAOYSA-N; [M+H]+; N-hydroxyundec-10-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; RAKAYJBOINMECV-UHFFFAOYNA-N; [M+H]+; microdiplactone
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.969; ANMBNLBZNBYCLE-UHFFFAOYSA-N; [M+H]+; methyl N-ethyl-N-(hept-4-en-1-yl)carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.941; PTJTVVNZVPUVNP-MJNBVBEVNA-N; [M+H]+; UNPD91661
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.941; ZMYQHFQMRLPPRB-WSYQHHSTNA-N; [M+H]+; UNPD147128
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.760; UBTBXKBPQCPOTA-RLXAYYKLNA-N; [M+H]+; UNPD112270
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.747; CZPCDIVNIKVJDW-UHFFFAOYSA-N; [M+H]+; 3-amino-4-cyclohexylcyclopentane-1,2-diol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.703; WNNYIIINIZJRMW-VBADPVMMNA-N; [M+H]+; Kinabalurine G;(+)-Kinabalurine G
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; QSFROPSPQWQTKU-UHFFFAOYSA-N; [M+H]+; 11-nitro-1-undecene
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; SLIAVDGEVKKHIC-UHFFFAOYSA-N; [M+H]+; 5-methyl-2-(propan-2-yl)cyclohexyl carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; ZUEKXFUSXSASAS-UHFFFAOYSA-N; [M+H]+; N-hydroxyundec-10-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.304; FYRZDTBPIGOXCS-UHFFFAOYSA-N; [M+H]+; 2-(2,2,6,6-tetramethylpiperidin-4-yl)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.113; DNSTUAQHBFISRZ-UHFFFAOYSA-N; [M+H]+; tert-butyl N-cyclohexylcarbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.611; AATMBDYQEPKVEN-UHFFFAOYSA-N; [M+H]+; ethyl 3-(3-methylpiperidin-1-yl)propanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.500; HBZHOIQNDVYHAH-UHFFFAOYSA-N; [M+H]+; 2-(dimethylamino)ethyl 2-cyclopentylacetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.493; HIAIZEPNWNXJBP-UHFFFAOYSA-N; [M+H]+; tert-butyl 2-piperidin-4-ylacetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.456; QZBSPLNCSRGMBA-UHFFFAOYSA-N; [M+H]+; tert-butyl azepane-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.448; XDTZRQLZSNTGSM-UHFFFAOYSA-N; [M+H]+; tert-butyl 4-aminocyclohexane-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.395; MGFRWLSGAABYES-VIFPVBQESA-N; [M+H]+; tert-butyl N-methyl-N-[(2S)-pent-4-en-2-yl]carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.379; SXQUKTMPHDAHMN-UHFFFAOYSA-N; [M+H]+; ethyl 2-methyl-2-piperidin-4-ylpropanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.352; NOVRXKFQWDPVJF-UHFFFAOYSA-N; [M+H]+; hexyl 3-(aziridin-1-yl)propanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.258; MDFWHHAKFURWJC-BDAKNGLRSA-N; [M+H]+; tert-butyl (1R,3S)-3-aminocyclohexane-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.258; LCYTVQCCTFSJQX-UHFFFAOYSA-N; [M+H]+; tert-butyl 4-methylpiperidine-4-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.256; QIMNOMITQVOFJZ-UHFFFAOYSA-N; [M+H]+; methyl 2,2,6,6-tetramethylpiperidine-4-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.247; UCLDINYUVODFTJ-UHFFFAOYSA-N; [M+H]+; ethyl 4-(ethylamino)cyclohexane-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.242; PQCNPWAMVMHDID-UHFFFAOYSA-N; [M+H]+; ethyl 2-[1-(aminomethyl)cyclohexyl]acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.240; AVBWGECREPOGMS-UHFFFAOYSA-N; [M+H]+; tert-butyl 3-methylpiperidine-4-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.239; BDRXMXIQSCEXQG-UHFFFAOYSA-N; [M+H]+; tert-butyl 2-piperidin-2-ylacetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.239; QFMGSKFYXCMEEY-UHFFFAOYSA-N; [M+H]+; tert-butyl 6-methylpiperidine-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.239; OWJYLBQNMSISIK-UHFFFAOYSA-N; [M+H]+; 2-(3,3-dimethylbutyl)pyrrolidine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.239; PJTBLEVEWWCANQ-UHFFFAOYSA-N; [M+H]+; tert-butyl 6-methylpiperidine-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.239; MPKJLVGZCOSWED-UHFFFAOYSA-N; [M+H]+; tert-butyl 5-methylpiperidine-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.239; WCPOCOGPKKHOIS-IUCAKERBSA-N; [M+H]+; tert-butyl (2S,3S)-2-methylpiperidine-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.229; YHARXZQFMJHMJT-UHFFFAOYSA-N; [M+H]+; 4-(oxan-2-ylmethoxy)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.217; SCOXNEUUDLBZHE-UHFFFAOYSA-N; [M+H]+; tert-butyl 4-methylpiperidine-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.217; LRTVQGZFCVLMLH-WDEREUQCSA-N; [M+H]+; (4aS,8aR)-4a,8a-dimethoxy-1,2,3,4,5,6,7,8-octahydroisoquinoline
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.217; KCVPRRNRTQVESK-SNVBAGLBSA-N; [M+H]+; methyl (2R)-2-amino-4-cyclohexylbutanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.217; BZXUONRQDZXVSL-UHFFFAOYSA-N; [M+H]+; 3,3-dimethyl-2,4-dioxaspiro[5.5]undecan-9-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.159; DHJKRRZIUOQEFW-VIFPVBQESA-N; [M+H]+; tert-butyl (2S)-2-methylpiperidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.145; JGQSREKJPFNXQH-UHFFFAOYSA-N; [M+H]+; tert-butyl 1-aminocyclohexane-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.138; NYJXAHCVTRDWEF-UHFFFAOYSA-N; [M+H]+; ethyl 2-amino-3-cyclohexylpropanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.136; SITJTKXMNWNRFB-UHFFFAOYSA-N; [M+H]+; 1-[3-(hydroxymethyl)piperidin-1-yl]-3-methylbutan-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.097; ZMIJRZZXFKLROL-UHFFFAOYSA-N; [M+H]+; methyl 4-(2-methylpiperidin-1-yl)butanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.092; WRDTYLDDOBYWRD-UHFFFAOYSA-N; [M+H]+; 1-(3-hydroxy-3-methylbutyl)azepan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.090; RGTNCOFLOIQTDF-UHFFFAOYSA-N; [M+H]+; methyl 3-(azepan-1-yl)-2-methylpropanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.090; LTXYOPKSTZSMLG-UHFFFAOYSA-N; [M+H]+; 4-(2-methylpiperidin-1-yl)pentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.090; MLUFYLXKVVKRGN-UHFFFAOYSA-N; [M+H]+; methyl 3-(2-methylazepan-1-yl)propanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.090; FZSBLLYQAULJDU-IUCAKERBSA-N; [M+H]+; tert-butyl (2S,5S)-2,5-dimethylpyrrolidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.090; HYTWIEIIVMAMHW-UHFFFAOYSA-N; [M+H]+; tert-butyl N-cyclopentyl-N-methylcarbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.089; NDOJWLCHAUMMPF-UHFFFAOYSA-N; [M+H]+; N-(5-methylhexan-2-yl)-3-oxobutanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.079; BBAUYLYRYIRCDS-UHFFFAOYSA-N; [M+H]+; methyl 5-tert-butylpiperidine-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.079; QJXNFCATCFLGBT-BDAKNGLRSA-N; [M+H]+; methyl 2-methyl-2-[(2S,4R)-4-methylpiperidin-2-yl]propanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.078; BFQUBOFIRCGKPE-UHFFFAOYSA-N; [M+H]+; 2,2-dimethyl-1-morpholin-4-ylpentan-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.076; KTWDFYADAJXZMB-XCVCLJGOSA-N; [M+H]+; (E)-5-methyl-6-morpholin-4-ylhex-4-en-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.069; GRJOHMIFRFCROR-UHFFFAOYSA-N; [M+H]+; ethyl 2-amino-2-cycloheptylacetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.069; VHDSGWBCAVRIRN-UHFFFAOYSA-N; [M+H]+; [1-[amino(oxan-4-yl)methyl]cyclobutyl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.069; IBSKPQSPTSJCFL-UHFFFAOYSA-N; [M+H]+; tert-butyl 3-amino-2-cyclobutylpropanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.069; IENHRIXBJKOMPS-UHFFFAOYSA-N; [M+H]+; ethyl 1-amino-3-tert-butylcyclobutane-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.507; ZUEKXFUSXSASAS-UHFFFAOYSA-N; [M+H]+; N-hydroxyundec-10-enamide
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C11H22N1O2; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 Âµm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 4.066
MS$FOCUSED_ION: PRECURSOR_M/Z 200.164517
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0udi-6190000000-2073521119c9b37eef4e
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  55.0545101 54.4510 55.055218 0.7629 16.37 0.2739 24 f{C4H7}/5.15ppm,p-C7H15N1O2
  55.9345916 10.6520 55.935303 1.2157 3.25 -0.0083 18 ?
  57.0701514 75.4498 57.070868 0.5782 20.53 -0.2957 24 f{C4H9}/4.81ppm,p-C7H13N1O2
  58.0653735 361.9042 58.066094 0.3961 22.48 0.9261 24 f{C3H8N1}/4.27ppm,p-C8H14O2
  59.0686621 10.0150 59.069386 1.2866 1.95 0.6331 20 ?
  67.0543315 14.5593 67.055073 0.9544 4.92 -0.5474 23 f{C5H7}/1.56ppm,p-C6H15N1O2
  69.0700141 31.1470 69.070757 0.9266 6.93 0.0026 24 f{C5H9}/1.99ppm,p-C6H13N1O2
  71.0491981 11.9209 71.049941 1.3793 4.15 0.1018 23 f{C4H7O1}/0.80ppm,p-C7H15N1O1
  72.0444742 33.9456 72.045217 0.9855 12.22 0.0478 24 f{C3H6N1O1}/1.17ppm,p-C8H16O1
  74.0965295 240.5713 74.097271 0.4049 78.27 -0.0791 24 f{C4H12N1}/1.40ppm,p-C7H10O2
  75.0998190 10.4764 75.100559 1.4248 3.53 -0.0195 20 ?
  80.9450591 12.1360 80.945786 1.1860 2.88 0.5189 22 ?
  81.0698771 20.4836 81.070604 0.8018 6.62 -0.0583 23 f{C6H9}/0.01ppm,p-C5H13N1O2
  83.0855271 31.3076 83.086247 0.8425 9.42 0.1098 20 f{C6H11}/0.00ppm,p-C5H11N1O2
  88.0756532 21.2048 88.076350 1.2943 4.17 0.4082 22 f{C4H10N1O1}/-0.42ppm,p-C7H12O1
  93.0698739 9.6244 93.070541 1.3001 3.12 -0.1103 17 f{C7H9}/-0.03ppm,p-C4H13N1O2
  95.0855059 16.2039 95.086158 1.1989 4.98 -0.1532 23 f{C7H11}/-0.22ppm,p-C4H11N1O2
  100.0757094 66.3687 100.076321 0.6795 21.93 0.1261 24 f{C5H10N1O1}/0.19ppm,p-C6H12O1
  102.0912647 17.2250 102.091858 1.3321 4.21 0.1182 21 f{C5H12N1O1}/-0.74ppm,p-C6H10O1
  114.0550581 17.9519 114.055549 1.3152 8.58 -0.0490 17 f{C5H8N1O2}/0.90ppm,p-C6H14
  116.9660180 15.6395 116.966485 1.2739 4.37 -0.0610 21 ?
  154.0862703 26.7761 154.086582 1.1617 11.06 -0.2134 23 f{C8H12N1O2}/0.10ppm,p-C3H10
  155.9747310 22.9821 155.975048 0.9489 4.98 0.3032 22 ?
  171.1489711 11.0419 171.149332 1.0751 2.64 -0.1035 19 ?
  177.9561528 15.0252 177.956534 1.5172 4.46 0.0245 17 ?
  194.9433370 26.9995 194.943770 0.9746 6.79 0.1166 18 ?
  199.1443733 36.2781 199.144820 1.0093 7.41 0.3360 23 ?
  200.1644507 999.0000 200.164900 0.3547 0.00 1.0000 24 f{C11H22N1O2}/-0.27ppm,p
  200.2005541 119.1407 200.201003 0.9141 25.64 -0.0383 24 ?
  200.9699912 19.2638 200.970439 1.1544 4.57 0.0882 17 ?
  201.1680354 109.7695 201.168483 0.8749 5.62 0.9557 24 ?
  201.2042297 13.6303 201.204677 1.6501 4.50 0.0684 19 ?
PK$NUM_PEAK: 32
PK$PEAK: m/z int. rel.int.
  55.054510 54.45 54
  55.934592 10.65 10
  57.070151 75.45 75
  58.065373 361.90 361
  59.068662 10.02 10
  67.054331 14.56 14
  69.070014 31.15 31
  71.049198 11.92 11
  72.044474 33.95 33
  74.096530 240.57 240
  75.099819 10.48 10
  80.945059 12.14 12
  81.069877 20.48 20
  83.085527 31.31 31
  88.075653 21.20 21
  93.069874 9.62 9
  95.085506 16.20 16
  100.075709 66.37 66
  102.091265 17.23 17
  114.055058 17.95 17
  116.966018 15.64 15
  154.086270 26.78 26
  155.974731 22.98 22
  171.148971 11.04 11
  177.956153 15.03 15
  194.943337 27.00 26
  199.144373 36.28 36
  200.164451 999.00 999
  200.200554 119.14 119
  200.969991 19.26 19
  201.168035 109.77 109
  201.204230 13.63 13
//
